Publication: 2979

BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)
      QxMD      Google Scholar   
Citation:
Mayo Clin Proc Innov Qual Outcomes vol 5 (6) 1012-1020
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
collection
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
11
Parents:
2751  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
Novartis, Genentech/Roche  
Grants:
U10CA180821, U10CA180882, U10CA180790, UG1CA189825, UG1CA189863, U24CA196171  
Corr. Author:
 
Authors:
                     
Networks:
IL043, LAPS-MN026, METROMIN, SANFORD   
Study
NCCTG-N0879
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
cfDNA, cell-free DNA, ddPCR, digital droplet polymerase chain reaction, FFPE, formalin-fixed paraffin-embedded, HR, hazard ratio, LDH, lactate dehydrogenase, MAPK, mitogen-activated protein kinase, NA, not available, NCCTG, North Central Cancer Treatment Group, NPV, negative predictive value, OS, overall survival, PFS, progression-free survival, PPV, positive predictive value